HTA5 Examining the Impact of Eams on NICE Recommendations over the Past Four Years von Ringger, D, Wissinger, E

Volltext

HTA318 Delays in NICE Highly Special Technology (HST) Appraisal for Medicines That Treat Ultra-Orphan Conditions von Ringger, D., Taylor, I.

Volltext

HTA76 Increased Legal Certainty Surrounding Medicine Discounting May Increase Switzerland’s Attractiveness As an Early Launch Country von Mumford, A., Ringger, D.

Volltext

HTA99 NICE Evaluations of Oncology Products With EMA Conditional Marketing Authorisation von Ringger, D, Mumford, A

Volltext

POSB173 Likelihood of UK Early Access Products to Receive a Positive NICE Recommendation von Torres, L, Ringger, D

Volltext

POSB265 Use of UK Early Access Data to Inform NICE Technology Appraisals von Ringger, D, Torres, L

Volltext

HPR132 Pricing Variations between Early Access Prices and List Prices in Switzerland von Edmonds, T., Ringger, D., Darlington, O.

Volltext

HPR30 Review of Indication-Based Pricing Practice in Switzerland von Ringger, D., Darlington, O., Mumford, A.

Volltext

HTA263 Evaluation of the UK Innovative Licensing and Access Pathway von Ringger, D, Taylor, I, Shaw, A

Volltext

HTA46 Key Issues in Health Economic Analysis in Nice Highly Specialised Technology Appraisals von Mumford, A, Ringger, D, Lewis, H

Volltext

HTA31 Health Economic Modelling Approaches in Cell and Gene Therapies von Mumford, A, Ringger, D, Lewis, H

Volltext

HTA97 Impact of EMA's Conditional Marketing Authorizations on the Benefit Assessment Validity Period in Germany: Insights From 2017-2023 von Konstanski, M, Beneke, L, Schmidt, K, Ringger, D

Volltext

POSB256 Innovative Contracting Schemes for Cell and Gene Therapies in France, Germany, Italy, Spain, and UK von Sopena, L, Ringger, D, Mumford, A

Volltext

HPR54 A Review and Evaluation of the UK’s Innovative Licensing and Access Pathway von Ringger, D., Shaw, A., Taylor, I., Greenwood, M., Mumford, A.

Volltext

HTA70 Early Patient Access to Life Saving Drugs across Europe – A Review of the Characteristics and Availability of Drugs in Early Access Programs in EU4 and the UK von Konstanski, M, Schmidt, K, Martinez J, Schepis, Sánchez-Martín, J., Ringger, D, Wissinger, E

Volltext

HTA200 Understanding Joint Clinical Assessment Scoping Requirements in Oncology: Results of a Rapid PICO Prediction Exercise Via an In-House Expert Network von Schmidt, K, Konstanski, M, Sauer, AK, Blank, P, Forsmark, A, Morel, B, Silva, E, Xemaire, E, Altmann, H, Schepis Martinez, J, Sánchez-Martín, J., Van den Eynde, K, Arregui, M, Berto, P, Rupčič, R, Ringger, D, O'Donnell, R

Volltext

PIN131 Is the Efficiency of Vaccine Pricing and Reimbursement Processes Comparable across European Countries? a European Overview of Nitags' Evaluation and Pricing Duration for Vac... von Desplanches, L., Charoy, M., Chavade, D., Schneider, B., Kersting, L., Ringger, D., Nikolettos, J., Pistillo, G., Piampiani, L., Garimberti, C., Volmer, T., Hill, C.A., Cattani, G., de Sauvebeuf, C.

Volltext

Pathophysiology of Lower Extremity Edema in Acute Heart Failure Revisited von Breidthardt, Tobias, MD, Irfan, Affan, MD, Klima, Theresia, MD, Drexler, Beatrice, MD, Balmelli, Cathrin, MD, Arenja, Nisha, MD, Socrates, Thenral, MD, Ringger, Rebekka, MD, Heinisch, Corinna, MD, Ziller, Ronny, MD, Schifferli, Jürg, MD, Meune, Christophe, MD, PhD, Mueller, Christian, MD

Volltext

L'Eglise-forte de Valère en Valais von Ringger, Harry

Volltext bestellen

TNF-α stimulates caspase-3 activation and apoptotic cell death in primary septo-hippocampal cultures von Zhao, Xiurong, Bausano, Brian, Pike, Brian R., Newcomb-Fernandez, Jennifer K., Wang, Kevin K.W., Shohami, Esther, Ringger, N.C., DeFord, S.M., Anderson, Douglas K., Hayes, Ronald L.

Volltext